Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

icate superior protection when compared to similar viral challenge studies for competitive vaccine designs currently in human clinical trials. We are therefore very excited about the potential for our vaccine."

Dr. McNally continued, "On the financial side, we continue to benefit from NIH/HVTN support of our human clinical trials and we are seeking additional government support to fund our internal research and development activities to expand the use of our technology against strains (clades) of the HIV virus affecting other areas of the globe. From December 2011 to March 2012, we raised a total of $2.7 million in equity capital to bolster our cash reserves."

Comment on Gilead Science's Truvada® Prevention SubmissionDr. McNally also commented on the recent news related to an advisory panel's recommendation that the FDA approve Gilead Science's submission of their anti-viral medication, Truvada, for prevention of HIV. "While any positive step towards the control of this deadly disease is greatly welcomed, we must continue the search for safe, cost-effective measures to prevent HIV transmission. The high cost of oral medications, patient compliance, and risk of medical side effects clearly suggest the best solution still lies with a preventive vaccine. GeoVax's preventive vaccine is considered a leading candidate for the version of the virus prevalent in North and South America, and Europe."

Financial ReviewGeoVax reported a net loss for the three months ended March 31, 2012 of $730,513, or $0.04 per share, based on 16.7 million weighted average shares outstanding. For the three months ended March 31, 2011, the Company reported a loss of $606,282, or $0.04 per share, based on 15.7 million weighted average shares outstanding.

The Company reported revenues of $854,063 for the three months ended March 31, 2012, related to its Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institutes
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Mapi ... Regulatory challenges through the drug development and commercialization process. ... include Global Strategic Regulatory services with the addition of ... previously announced acquisition . CanReg is one of ... exclusively to regulatory affairs for life sciences companies. With ...
(Date:3/3/2015)... MENLO PARK, Calif. , March 3, 2015   ... a biopharmaceutical company focused on developing and commercializing proven cancer ... will be presenting at the 27th Annual ROTH Conference ... Laguna Niguel , in Dana Point, ... DelMar,s president and CEO, will present on Tuesday, March 10, ...
(Date:3/3/2015)... -- STAAR Surgical Company (NASDAQ: STAA ) a leading ... for the eye, has named Caren Mason President ... elected to STAAR,s Board of Directors in June 2014, and ... Regulatory Committee in September 2014, replaces Barry G. Caldwell ... Ms. Mason joins STAAR after most recently serving as ...
Breaking Medicine Technology:Mapi incorporates Strategic Regulatory Services to support life-science product Commercialization and Health Research 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 3Caren Mason Appointed President & CEO of STAAR Surgical Company 2Caren Mason Appointed President & CEO of STAAR Surgical Company 3Caren Mason Appointed President & CEO of STAAR Surgical Company 4Caren Mason Appointed President & CEO of STAAR Surgical Company 5
... , , ... data from a clinical study of ENB-0040, a bone ... of hypophosphatasia (HPP). After six months of treatment with ... improvements in bone mineralization, correction of skeletal defects, better ...
... , MONMOUTH JUNCTION, N.J., Sept. 14 Transave, ... trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead ... Phase II data indicated that ARIKACE, delivered once daily for ... as measured by patient and physician reported outcomes and reduction ...
Cached Medicine Technology:Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 2Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 3Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 4
(Date:3/3/2015)... Venato, a secure cloud-based credential ... flagship software solution now provides an automated mechanism ... to the National Healthcare Safety Network (NHSN). ... require that hospitals submit healthcare personnel (HCP) influenza ... May 15 for each influenza season in order ...
(Date:3/3/2015)... San Rafael, CA (PRWEB) March 03, 2015 ... basketball talent. Global sports icon, Michael Jordan, brought a level ... before, and has yet to experience again since his Chicago ... frenzy in city that exists to this day. This era ... the premier global basketball brand. Due to this rich basketball ...
(Date:3/3/2015)... March 03, 2015 United Benefit Advisors ... is pleased to welcome The Gehring Group, Inc. as ... services for more than 20 years, The Gehring Group ... and risk management consulting firm that serves organizations in ... risk management programs. , Based in Palm ...
(Date:3/3/2015)... March 03, 2015 After the holiday ... lifestyle of fitness and exercise. Community Health Center of ... presenting 6 ways that families in Everett, Marysville, and ... winter months. , CHC says, “While it’s relatively ... and steamed veggies, many families wonder how to keep ...
(Date:3/3/2015)... Extend Nutrition, a leading nutritional snack company with ... consumed at the next meal by an average of 21%* ... lifestyle changes needed and no program to abide by. Consumers ... starter kit contains 60 servings of nutritional bars, shakes, and ... healthy fat and complex carbohydrates that helps to control blood ...
Breaking Medicine News(10 mins):Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3
... pediatric study conducted by Vinay Nadkarni, MD, and Peter ... at The Children's Hospital of Philadelphia it is found ... This is a life-threatening disordered heart rhythms that may ... develops later during the arrest at the time of ...
... endorsed the plan for the closure of two facilities which ... in the region//. NHS Borders has since been planning the ... ,Shutting down the Jedburgh Cottage Hospital and the cottage hospital ... October. The 60 staff involved are expected to be deployed ...
... According to latest figures revealed in Ireland, suicide is the most ... the age of 35years//. There were 431 registered suicides in 2005,with ... , The HSE today appealed to the media not to ... were preventable. , , “We are ...
... as of now 15 people have died. Hence the ... to fight polio. // This campaign would cost 395 ... the health ministry. On the whole about 96 people ... African country. Namibian President Hifikepunye Pohamba, asked the people ...
... here used an animal vaccine supplied to it "by ... a doctor //and storekeeper, authorities said Wednesday. ... Laboratory Pvt Ltd, which provided the vaccine to the ... doctors at the hospital found out that medicines meant ...
... juvenile dermatomyositis (JDM), a protein present in chronic inflammatory ... //to trigger T-cells response – which is associated with ... Elst finds. ,The specific response has earlier ... little is known about the role of HSP60 in ...
Cached Medicine News:Health News:Proteins – A New Way to Treat Children's Muscle Diseas 2
... Provides stable positioning of a patient during ... used for stable positioning of a patient during ... to attach directly to the operating table utilizing ... are made of semi-dense foam to help prevent ...
... The Multilok Hand Operating Table ... the hand and spatial positioning of ... micro-surgical procedures of the hand, fingers ... modular system with re-usable base and ...
... M3-X Extremity Fixation System is a rigid fixation ... It offers modular instrumentation and a superior ... M3-X features four sizes of true lag ... and foot. OSTEOMED's lag screw design eliminates ...
The Hydroflex Arthroscopic Irrigation Pump is simple to transport, set-up and tear down. The pump is streamlined with a simple control panel an no transducers or electronics to control flow. It is co...
Medicine Products: